Tickerplace logo

Tickerplace

Prime Medicine, Inc. logo

PRMEPrime Medicine, Inc.

PRME Stock Price, Valuation & Chart | Prime Medicine, Inc.

Compare
$3.670+0.10 (+2.80%)

At close · 02 Sept 2026, 08:00 pm

Sector: HealthcareIndustry: BiotechnologyPRME intrinsic valuePRME calculated fair value vs price
OverviewFinancialsDividendsRatios

PRME Historical price chart

PRME Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization662.87M
PE Ratio-3.46
EPS-1.06
Trading Volume2.46M
Today's High/Low3.71/3.47
Dividend Yield0.00
52 Week High/Low6.94/2.67
Shares Outstanding180.62M
PRME Financial Statement
PRME Analyst ratings
PRME Analysis & performance metrics

PRME Company profile

Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. It offers Prime Editors with a Prime…

PRME Management team

Management
Jeremy S. Duffield M.D., Ph.D.
Chief Scientific Officer
Total 1 executive

PRME Frequently asked questions

What is Prime Medicine, Inc. (PRME) Stock Price?

Current stock price of Prime Medicine, Inc. (PRME) stock is $3.670. The stock price is +2.80% higher in the session. The intraday range can be seen from this page. Volume of Prime Medicine, Inc. (PRME) stock is 2.46M.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Prime Medicine, Inc. (PRME) stock price going up or down today?

The stock price of Prime Medicine, Inc. (PRME) can change with earnings, company news, and overall market sentiment. Prime Medicine, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Prime Medicine, Inc. stock expensive at its current price?

Whether Prime Medicine, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for PRME on this page is -3.46. EPS on this page is -1.06. Compare those figures with peers and growth expectations before deciding if the current Prime Medicine, Inc. price is justified.

How has the stock price of Prime Medicine, Inc. (PRME) performed historically?

Historical performance for Prime Medicine, Inc. (PRME) is shown on the price chart on this page. Review multi-period moves alongside volume to see how PRME reacted to past earnings and market events.

Should I buy Prime Medicine, Inc. (PRME) stock, at this price?

Buying Prime Medicine, Inc. (PRME) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.